Asia-Pacific monoclonal antibodies market is estimated to grow at a CAGR of 8.9% during the forecast period. Significant rise in the incidences of cancer and infectious diseases and increasing approvals of biosimilars are primarily encouraging the market growth.
Please read the originial post here: https://www.omrglobal.com/industry-reports/asia-pacific-monoclonal-antibodies-market
